Vanguard updates its Cabaletta Bio (CABA) stake, reporting sole voting power over 1.04M shares.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Vanguard Capital Management has filed an amended passive investment disclosure (SCHEDULE 13G/A) for Cabaletta Bio, Inc. (CABA), reporting beneficial ownership of 8,187,183 common shares, representing 3.79% of the class as of September 30, 2026. The filing indicates Vanguard has sole voting power over 1,042,425 shares and sole dispositive power over all 8,187,183 shares.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.